Skip to main content
. 2024 Jul 27;17(8):993. doi: 10.3390/ph17080993

Table 6.

The anticancer activities of Halodule uninervis.

Extract Dose Experimental Model Observations References
Ethyl acetate extract 25, 50, and 100 mg/mL
  • -

    Method: MTT 1 assay, AO/EtBr staining, DNA fragmentation assay

  • -

    Cells: A375, A549, HeLa, HT29.

  • -

    Concentration-dependent decrease in cell viability against all tested cell lines.

  • -

    Highest activity against A549 cell line via the induction of apoptosis.

  • -

    Treated cells exhibited morphological changes including shrinkage, distortion, and rounded.

[16]
Methanol/chloroform extract 100–1000 mg/mL
  • -

    Method: SRB 2 assay.

  • -

    Cells: MCF-7, DU-145, HeLa, SKOV-3), PANC-1.

  • -

    Only the crude extract showed a potent cytotoxicity against SKOV-3 cell (IC50 0.52 mg/mL)

  • -

    Crude extract exhibited the highest cytotoxic activity against MCF-7 cells (IC50 2.30 mg/mL) among other treatments.

[15]
Chloroform fraction 100–1000 mg/mL
  • -

    Method: SRB assay.

  • -

    Cells: MCF-7, DU-145, HeLa, SKOV-3), PANC-1.

  • -

    Activity against DU-145 and PANC-1 cells.

[15]
FAs content 100–1000 mg/mL
  • -

    Method: SRB assay.

  • -

    Cells: MCF-7, DU-145, HeLa, SKOV-3), PANC-1.

  • -

    Activity against DU-145 and HeLa cells.

[15]
USM 3 content 100–1000 mg/mL
  • -

    Method: SRB assay.

  • -

    Cells: MCF-7, DU-145, HeLa, SKOV-3), PANC-1.

  • -

    Activity only against MCF-7 cells.

[15]
Ethanolic extract of the leaves 100 and 200 μg/mL
  • -

    Method: proliferation assays (MTT and cell cycle analysis), cancer phenotype assay (migration, invasion, aggregation, and adhesion), and in ovo assay.

  • -

    Cells: MDA-MB-231.

  • -

    Dose- and time-dependent decrease in proliferation by inducing cell cycle arrest and activating apoptosis.

  • -

    Attenuation of cancer metastasis by inhibiting cell migration, invasion, adhesion, aggregation, and angiogenesis.

  • -

    Downregulation of STAT3 signaling pathway.

[56]

1 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; 2 Sulforhodamine B; 3 Unsaponifiable matter.